journal article·2026-07-14

Orally Delivered Co@NCNH/NC Nanoparticles and an Adhesive Magnetic Microneedle Patch for Magnetically Amplified Bioelectronic Therapy of Colorectal Cancer

Weichen Zhang, Ruiyan Li, Hongyang Niu, Yueyue Fan, Mengyu Yuan, Gaoli Niu, Li Wang, Yong Kang, Dehua Xia, Xiangyang Yu, Xiaoyuan Ji

Publisher page

Abstract

ABSTRACT Effective management of colorectal cancer remains hindered by inadequate local drug retention, poor intratumoral penetration, and profound immunosuppression. Here, we developed a magnetically amplified bioelectronic platform integrating orally ingestible Co@NCNH/NC nanoparticles with an adhesive magnetic microneedle patch, operating under a rotating magnetic field (RMF). Co@NCNH/NC nanoparticles are cobalt‐infused nitrogen‐doped carbon hybrids with magnetic responsiveness and robust interfacial electroactivity. The microneedle patch features a polydopamine‐modified gelatin methacryloyl adhesive base for stable wet‐tissue fixation onto the colonic wall and magnetized tips that facilitate local magnetic enrichment of Co@NCNH/NC nanoparticles. After oral administration, Co@NCNH/NC nanoparticles transit to the colorectal region, where the microneedle patch captures and concentrates them at the tumor site, enhancing local retention and penetration. Under RMF stimulation, the microneedle tips and retained Co@NCNH/NC nanoparticles cooperatively generate intensified local electrical and electrochemical outputs, triggering mitochondrial depolarization, DNA damage, calcium overload, and concurrent apoptosis and pyroptosis. Critically, this bioelectrical insult provokes robust immunogenic responses—including calreticulin exposure and High Mobility Group Box 1 release—that promote dendritic cell maturation, macrophage M1 repolarization, elevated NK cell infiltration, and augmented CD4 + and CD8 + T‐cell activity. In orthotopic colorectal tumor‐bearing mice, this combination treatment markedly suppresses primary tumor growth and intra‐abdominal metastasis, prolongs survival, and remodels tumor‐associated gut microbial dysbiosis.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advancements in Transdermal Drug Delivery · Microbial Inactivation Methods · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Academy of Medical Engineering and Translational Medicine Medical College Tianjin University Tianjin China

State Key Laboratory of Advanced Medical Materials and Devices Tianjin University Tianjin China

The First Affiliated Hospital of Henan Polytechnic University Jiaozuo China

School of Environmental Science and Engineering Sun Yat‐sen University Guangzhou China

Department of Gastric Surgery National Clinical Research Center for Cancer Tianjin Key Laboratory of Digestive Cancer Tianjin Medical University Cancer Institute & Hospital Tianjin's Clinical Research Center for Cancer Tianjin China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Tianjin Municipality

References (46)

Show source-provided references
1. 10.3322/caac.2166010.3322/caac.21660 ↗
2. 10.3238/arztebl.m2021.037510.3238/arztebl.m2021.0375 ↗
3. 10.1136/gutjnl‐2022‐32773610.1136/gutjnl‐2022‐327736 ↗
4. 10.3322/caac.2149210.3322/caac.21492 ↗
5. 10.1158/0008‐5472.CAN‐21‐277810.1158/0008‐5472.CAN‐21‐2778 ↗
6. 10.1038/s41568‐025‐00872‐110.1038/s41568‐025‐00872‐1 ↗
7. 10.1016/j.ccell.2022.08.01710.1016/j.ccell.2022.08.017 ↗
8. 10.1038/s41575‐024‐00900‐910.1038/s41575‐024‐00900‐9 ↗
9. 10.1016/S0140‐6736(24)00360‐X10.1016/S0140‐6736(24)00360‐X ↗
10. 10.1021/acsnano.5c1973910.1021/acsnano.5c19739 ↗
11. 10.1038/s41392‐025‐02186‐y10.1038/s41392‐025‐02186‐y ↗
12. 10.1021/acsnano.2c0198910.1021/acsnano.2c01989 ↗
13. 10.1002/adma.20250986510.1002/adma.202509865 ↗
14. 10.1016/j.tim.2019.12.00810.1016/j.tim.2019.12.008 ↗
15. 10.1002/adma.20251239910.1002/adma.202512399 ↗
16. 10.1111/brv.1280410.1111/brv.12804 ↗
17. 10.1002/adhm.20210064610.1002/adhm.202100646 ↗
18. 10.1002/adma.20250588010.1002/adma.202505880 ↗
19. 10.1038/s41586‐025‐09706‐410.1038/s41586‐025‐09706‐4 ↗
20. 10.1016/j.biomaterials.2025.12356910.1016/j.biomaterials.2025.123569 ↗
21. 10.1002/adma.20231115410.1002/adma.202311154 ↗
22. 10.1002/adma.7276310.1002/adma.72763 ↗
23. 10.1126/sciadv.adv168210.1126/sciadv.adv1682 ↗
24. 10.1038/s41467‐024‐48058‐x10.1038/s41467‐024‐48058‐x ↗
25. 10.1002/adfm.20251075110.1002/adfm.202510751 ↗
26. 10.1038/s41467‐025‐56768‐z10.1038/s41467‐025‐56768‐z ↗
27. 10.1038/s41467‐025‐57045‐910.1038/s41467‐025‐57045‐9 ↗
28. 10.1021/jacs.5c0836810.1021/jacs.5c08368 ↗
29. 10.1021/acsnano.5c0174410.1021/acsnano.5c01744 ↗
30. 10.1038/s41467‐025‐58075‐z10.1038/s41467‐025‐58075‐z ↗
31. 10.1016/j.jconrel.2024.10.04210.1016/j.jconrel.2024.10.042 ↗
32. 10.1126/sciadv.adh221310.1126/sciadv.adh2213 ↗
33. 10.1016/j.apmt.2024.10238210.1016/j.apmt.2024.102382 ↗
34. 10.7150/thno.12286510.7150/thno.122865 ↗
35. 10.1038/s44222‐023‐00141‐610.1038/s44222‐023‐00141‐6 ↗
36. 10.1016/j.device.2023.10005310.1016/j.device.2023.100053 ↗
37. 10.1126/sciadv.adj706710.1126/sciadv.adj7067 ↗
38. 10.1016/j.actamat.2026.12227210.1016/j.actamat.2026.122272 ↗
39. 10.1002/adma.20241235310.1002/adma.202412353 ↗
40. 10.1016/j.actamat.2023.11923910.1016/j.actamat.2023.119239 ↗
41. 10.1021/acsami.1c1004810.1021/acsami.1c10048 ↗
42. 10.1002/adfm.20241952010.1002/adfm.202419520 ↗
43. 10.1002/adfm.20230427610.1002/adfm.202304276 ↗
44. 10.1021/jacs.5c1955110.1021/jacs.5c19551 ↗
45. 10.1016/j.scib.2023.10.00410.1016/j.scib.2023.10.004 ↗
46. 10.1038/s41551‐025‐01609‐z10.1038/s41551‐025‐01609‐z ↗